ProSciento ProSciento
chat icon
Get in Touch
Contact Us
Enroll in a Study

Resources | News Releases


June 7, 2022 |
News Releases
ProSciento Hosts the 5th NASH Roundtable Virtual Forum Focused on Digital Pathology for Histology in NASH Drug Development
May 23, 2022 |
News Releases
ProSciento Appoints Dr. Michelle Mazuranic as Vice President of Medical and Regulatory Affairs
December 10, 2021 |
News Releases
Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum
November 30, 2021 |
News Releases
ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks
November 10, 2021 |
News Releases
ProSciento Appoints Lynn Rudolph as Vice President of Human Resources
November 1, 2021 |
News Releases
ProSciento Co-Hosts the 4th Annual NASH Roundtable Virtual Forum
July 8, 2021 |
News Releases
ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science
September 10, 2020 |
News Releases
ProSciento Closes Growth Financing from 1315 Capital
September 1, 2020 |
News Releases
ProSciento Appoints Stephen Mullennix as Chief Financial Officer
June 15, 2020 |
News Releases
ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California
February 6, 2020 |
News Releases
ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)
November 12, 2019 |
News Releases
ProSciento to Present at the Diabetes Technology Annual Meeting
August 13, 2019 |
News Releases
ProSciento Expands Senior Management Team, Appoints Siva Mullapudi as Senior Director of CRO Services
August 5, 2019 |
News Releases
ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting
June 17, 2019 |
News Releases
ProSciento Expands Executive Team, Appoints Helge Guenther as Chief Information Officer
May 29, 2019 |
News Releases
ProSciento to Present at the American Diabetes Association 79th Scientific Sessions
April 15, 2019 |
News Releases
ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit
April 10, 2019 |
News Releases
Second Edition Textbook, ‘Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,’ Provides Roadmap for Preclinical and Clinical Research
March 19, 2019 |
News Releases
ProSciento Hosts Second NASH Roundtable of Leading Experts During the International Liver Congress in Vienna
January 2, 2019 |
News Releases
ProSciento Announces Poster Presentation at the 2019 NASH-TAG Conference
December 5, 2018 |
News Releases
ProSciento Forms NASH Roundtable, a Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs
October 26, 2018 |
News Releases
ProSciento Hosts Inaugural NASH Roundtable of Leading Experts at AASLD Annual Meeting
September 27, 2018 |
News Releases
ProSciento to Present at the 54th European Association for the Study of Diabetes (EASD) Annual Meeting
August 6, 2018 |
News Releases
ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer
June 21, 2018 |
News Releases
ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials
June 19, 2018 |
News Releases
ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team
June 13, 2018 |
News Releases
ProSciento to Present at the American Diabetes Association 78th Scientific Sessions
April 19, 2018 |
News Releases
ProSciento Presents Scientific Data at the 2nd Annual Nash Summit
March 7, 2018 |
News Releases
ProSciento Expands Asia Pacific Operations with Office in Australia
November 6, 2017 |
News Releases
ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit
September 9, 2017 |
News Releases
ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon
June 7, 2017 |
News Releases
ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment
June 6, 2017 |
News Releases
ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego
May 30, 2017 |
News Releases
ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors
May 1, 2017 |
News Releases
ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop
February 15, 2017 |
News Releases
mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population
September 14, 2016 |
News Releases
ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research
July 28, 2016 |
News Releases
ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH
June 10, 2016 |
News Releases
ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism
June 9, 2016 |
News Releases
 ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions
June 6, 2016 |
News Releases
ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans
April 5, 2016 |
News Releases
ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego
November 24, 2015 |
News Releases
ProSciento Appoints Meryl Wiernik as Senior Director of CRO Services
November 9, 2015 |
News Releases
Congratulations to Hanmi Pharmaceutical Co., Ltd.
October 29, 2015 |
News Releases
ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego
October 28, 2015 |
News Releases
ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research
October 28, 2015 |
News Releases
ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH
October 13, 2015 |
News Releases
ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year
October 8, 2015 |
News Releases
ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development
September 10, 2015 |
News Releases
ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting
June 4, 2015 |
News Releases
ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership
May 29, 2015 |
News Releases
ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston
May 7, 2015 |
News Releases
ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt
April 15, 2015 |
News Releases
ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego
January 22, 2015 |
News Releases
New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods
ProSciento ProSciento

© 2022 ProSciento All rights reserved

ProSciento Headquarters
6160 Cornerstone Ct. E
San Diego, CA 92121
(p) +1 (619) 427-1300 ext. 100
(f) +1 (619) 427-1307

Stay Connected

Sign up for ProSciento's news and publication updates.

Subscribe

Social Media

Explore

  • About Us
  • Services
  • Metabolic Focus
  • Specialized Methods
  • Resources
  • Careers
  • Contact Us

Legal

  • Privacy Policy
  • Anti-Corruption Policy
  • Terms of Use
  • HIPAA Notice
menu
  • About Us
    • Overview
    • Leadership
    • Corporate Values
    • Events
  • Metabolic Focus
    • Overview
    • Diabetes
    • NASH (Nonalcoholic Steatohepatitis)
    • Obesity
  • Services
  • Specialized Methods
  • Resources
    • Publication Library
    • News Releases
  • Careers
  • Enroll in Study
  • Join Our Site Network
  • Contact Us

Our website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. For additional details on what cookies are in use, options for accepting cookies, and to review our privacy policy, please view privacy settings.

ProSciento
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information, such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

Analytics cookies used:

  • LinkedIn
  • Twitter
  • Facebook
  • Google Tag Manager
  • GStatic
  • Google Ad Words

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Privacy Policy

More information about our Cookie Policy can be found within our Privacy Policy